Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer Top Pharma Social Brand
Media Post
Wednesday, April 15, 2009 - 9:25am
tags:
Pfizer, social media
Cancer pills suffer from red tape
Fierce Pharma
Wednesday, April 15, 2009 - 9:24am
tags:
cancer, insurance
Highlights from Day 1: Pharmaceutical Strategic Outlook Conference
InVivo
Wednesday, April 15, 2009 - 9:10am
tags:
J&J CFO Says Slump’s Effect on Company Won’t Worsen
Bloomberg
Wednesday, April 15, 2009 - 9:02am
tags:
JNJ
Merck licenses Santen eye drug for undisclosed sum
Yahoo/AP
Wednesday, April 15, 2009 - 8:58am
tags:
Merck, licensing, Santen, tafluprost
Sales of Abbott's Humira Shy Of Projections
TheStreet.com
Wednesday, April 15, 2009 - 8:40am
tags:
Abbott Laboratories, Humira, earnings
Abbott profit helped by special gains
Yahoo/Reuters
Wednesday, April 15, 2009 - 8:30am
tags:
Abbott Laboratories, earnings
After Falling for Fake Clinical Trial, Review Board Steps Aside
WSJ Online
Wednesday, April 15, 2009 - 8:17am
tags:
drug trials
P&G backs drug in deal to pay insurer
Yahoo/AP
Wednesday, April 15, 2009 - 8:11am
tags:
Proctor & Gamble, osteoporosis, Actonel
Sanofi-Aventis to Buy Cancer Drug Firm BiPar
TheStreet.com
Wednesday, April 15, 2009 - 7:29am
tags:
Sanofi, cancer, Bi-Par, buyouts, PARP inhibitors
Vertex Down on High Volume
Yahoo/Zacks.com
Wednesday, April 15, 2009 - 7:29am
tags:
Vertex Pharmaceuticals
Genentech Executives Start Leaving After Roche Deal
Bloomberg
Wednesday, April 15, 2009 - 7:28am
tags:
Genentech, Roche, buyouts, reorganization
Dendreon Options Soar as Cancer Study Lifts Shares
Bloomberg
Wednesday, April 15, 2009 - 7:27am
tags:
Dendreon, Provenge, prostate cancer
Pfizer Gets Its Irish Up
CNBC
Wednesday, April 15, 2009 - 7:26am
tags:
Pfizer, Viagra, Ireland
Cell Therapeutics gets $15 million cash
Bizjournals.com
Tuesday, April 14, 2009 - 10:09am
tags:
Cell Therapeutics
Botox Rival Faces Delay in FDA Marketing Approval
Bloomberg
Tuesday, April 14, 2009 - 10:07am
tags:
Botox, FDA, Allergan, Medicis, Reloxin
Bristol-Myers on the Prowl for Deals – BMY, PFE, MRK, AZN
Stock Traders Daily
Tuesday, April 14, 2009 - 10:04am
tags:
Bristol-Myers Squibb, Pfizer, Merck, Wyeth, Schering Plough, AstraZeneca, Exelixis
Drug Makers Talk Up Comparative Effectiveness, Sort Of
WSJ Online
Tuesday, April 14, 2009 - 9:59am
tags:
AstraZeneca, drug industry
Dendreon: Provenge 'Significantly' Extends Survival
TheStreet.com
Tuesday, April 14, 2009 - 8:54am
tags:
Dendreon, Provenge, IMPACT, prostate cancer
Genzyme's Termeer made almost $14 million
Bizjournals.com
Tuesday, April 14, 2009 - 8:53am
tags:
Genzyme, Termeer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.